Epigral Ltd
No trades
No trades
Fundamentals and stats
Top segments and regional performance
Last year, the company generated 25.27 B INR, the most of which — 24.44 B INR — came from its top-performing segment, Chlor Alkali & Its Derivatives, compared to 24.67 B INR the previous year. The greatest contribution came from India, which accounted for 24.18 B INR last year, with 23.45 B INR the year before.
By source
By country